Intellectual Property, Patent, Trademark & Copyright Law Updates

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
May
3
2014
PTAB (Patent and Trial Appeal Board) Not a “Death Squad”—More Like a Surgeon McDermott Will & Emery
May
3
2014
It’s Not All that Bleak for Patent Owners at the PTAB (Patent Trial and Appeal Board) McDermott Will & Emery
May
2
2014
"Stone Lion Capital" Likely to Cause Consumer Confusion with "Lion" and "Lion Capital" McDermott Will & Emery
May
2
2014
An Order Denying Summary Judgment Is Not an Appealable Final Judgment McDermott Will & Emery
May
2
2014
PTAB (Patent Trial and Appeal Board): The Name of the Game Is the Claim McDermott Will & Emery
May
2
2014
Civil Contempt Only Applies if Party Violates Explicit Terms of Order McDermott Will & Emery
May
2
2014
Multivariate-Hedonic-Regression Damage Analysis Found to Be an Impermissible Rule of Thumb McDermott Will & Emery
May
2
2014
United States Patent and Trademark Office (USPTO) Introduces Glossary Pilot Program McDermott Will & Emery
May
2
2014
In re Bergstrom – A Lost Precedent That Should Be “Found”
May
2
2014
On Remand, Federal Circuit Comes Around to Supreme Court’s Way of Thinking McDermott Will & Emery
May
2
2014
PTO Litigation Center Report – May 2, 2014 Sterne, Kessler, Goldstein & Fox P.L.L.C.
May
1
2014
Implied License Limited to Continuation Applications, Not to Provisionals Re: Licensed Pharmaceutical Patents McDermott Will & Emery
May
1
2014
Supreme Court Grants Greater Discretion to District Courts to Award Fees in Patent Cases Vedder Price
May
1
2014
A Prosecution History Without Express Disclaimers Still Informs Claim Construction re: Intellectual Property McDermott Will & Emery
May
1
2014
A Claim of “Authorship” Does Not Raise an Inventorship Dispute McDermott Will & Emery
May
1
2014
Rainbow International Seeks Restoration Of Exclusive Use Of Its Marks Womble Bond Dickinson (US) LLP
May
1
2014
Pre-Patent Issuance Activities Can Create Justiciable Controversy McDermott Will & Emery
May
1
2014
When Is a Claimed Drug Formulation Enabled and Adequately Described? McDermott Will & Emery
May
1
2014
PTO Litigation Center Report – May 1, 2014 Sterne, Kessler, Goldstein & Fox P.L.L.C.
May
1
2014
Narrowing Colour Claims Re: Christian Louboutin Trademark Katten
May
1
2014
Product May Acquire Non-Infringing Status, Even as to Adjudicated Method Claims, After a Prior Finding of Non-Infringement of Apparatus Claims McDermott Will & Emery
Apr
30
2014
Claim Preclusion Bars Second Lawsuit on Reexamined Claims Previously Held Invalid McDermott Will & Emery
Apr
30
2014
Lack of Intent Must Be Proved for All Times After Learning of a Patent McDermott Will & Emery
Apr
30
2014
The Thorny Problem of Patentable Eligible Subject Matter: Part 1 of a 10-Part Series: U.S Michael Best & Friedrich LLP
Apr
30
2014
Exceptional Case Finding Results in $12 Million in Attorney's Fees Award McDermott Will & Emery
Apr
30
2014
Therasense and the Fight for Fees on Attorney Fees McDermott Will & Emery
Apr
30
2014
High Octane Fuel for Curbing Abusive Patent Litigation Re: Supreme Court Ruling Bracewell LLP
Apr
30
2014
Supreme Court Lowers Threshold for Grant of Attorneys’ Fees in Patent Cases Barnes & Thornburg LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins